| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $365K | -10.9% | -16.3% |
| SG&A Expense | $1.7M | +6.4% | -5.1% |
| Operating Income | -$20.8M | -915.2% | -814.3% |
| Pre-tax Income | -$20.7M | -834.2% | -760.3% |
| Income Tax | -$852K | — | — |
| Net Income | -$19.8M | -795.6% | -724.8% |
| EPS (Basic) | -$2.56 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $996K | +81.3% | +155.0% |
| Total Assets | $1.0M | -94.7% | -94.6% |
| Current Liabilities | $12.8M | +0.6% | +10.6% |
| Total Liabilities | $12.8M | -5.7% | +3.0% |
| Stockholders' Equity | -$11.7M | -292.2% | -266.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | — |
| Financing Cash Flow | $3.7M | — | — |
| -5.3% |
| EPS (Diluted) | -$2.56 | -456.5% | -5.3% |